INMB
INmune Bio·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-21
Latest data update time: Updated on 2026-03-21
2.63 / 10Overall Score
UnderperformInvestment Rating
2.63 / 10Overall Score
UnderperformInvestment Rating
Is INMB a Buy, Sell, or Hold?
- Based on a composite score of 2.63/10, we rate INMB as a Underperform. Our analysis breaks down into 0.61/10 for Fundamentals, 2.51/10 for Technicals, and 3.71/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Technical Analysis of INMB?
Is INMB undervalued or overvalued?
What is the analyst consensus for INMB?
Is INMB a Buy, Sell, or Hold?
- Based on a composite score of 2.63/10, we rate INMB as a Underperform. Our analysis breaks down into 0.61/10 for Fundamentals, 2.51/10 for Technicals, and 3.71/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is INMB undervalued or overvalued?
Technical Analysis of INMB?
What is the analyst consensus for INMB?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
